Measles Explodes in Bangladesh After Vaccination Breakdown, Killing Hundreds of Children

Why It Matters

The crisis demonstrates how political instability can rapidly erode public‑health gains, threatening millions of children and regional disease control efforts. It underscores the urgency for resilient vaccine supply chains and swift emergency response mechanisms.

Key Takeaways

• Over 32,000 suspected cases and 250 child deaths.
• Vaccination coverage fell to 59% after procurement overhaul.
• UNICEF supply halted; open‑tender delays caused nationwide stockouts.
• Emergency MR campaign launched April, but outbreak continues.
• Malnutrition amplifies severity, stressing fragile health system.

Pulse Analysis

The Bangladesh measles surge highlights a perfect storm of political disruption and public‑health fragility. After the 2024 revolution, the interim government replaced the long‑standing UNICEF‑Gavi procurement model with an open‑tender system that stalled vaccine orders. This policy shift, combined with the cancellation of a planned supplemental immunization campaign, drove routine coverage below the 95% herd‑immunity threshold, creating a vacuum that the virus quickly exploited. The situation illustrates how even countries with historically high vaccination rates can become vulnerable when supply chains are politicized.

Beyond the immediate supply gap, Bangladesh’s broader health challenges amplified the outbreak’s lethality. High rates of child malnutrition, vitamin A deficiency, and under‑funded clinics mean that measles infections progress to severe disease more often, increasing hospitalization and mortality. The epidemic now spans 58 of 64 districts, straining already overburdened hospitals where children are treated on floors due to bed shortages. These systemic weaknesses underscore the need for integrated nutrition and health interventions alongside immunization efforts.

The emergency response, launched in April, aims to vaccinate children aged six months to five years in high‑risk zones before rolling out nationwide. While the campaign restores UNICEF‑supplied measles‑rubella vaccine, logistical hurdles and limited coverage mean it will not instantly reverse the epidemic’s trajectory. Experts call for a formal public‑health emergency declaration to mobilize resources, accelerate vaccine delivery, and resume vitamin A supplementation. The Bangladesh case serves as a cautionary tale for other low‑ and middle‑income nations: maintaining transparent, resilient vaccine procurement and rapid response capacity is essential to safeguard hard‑won disease‑elimination gains.